SPI
17.997,78
PKT
-356,01
PKT
-1,94
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.12.12 | SGS SA buy | Vontobel Research | |
| 19.12.12 | Lonza hold | Vontobel Research | |
| 19.12.12 | UBS buy | Vontobel Research | |
| 18.12.12 | Holcim buy | Banc of America Securities-Merrill Lynch | |
| 18.12.12 | Holcim overweight | J.P. Morgan Cazenove | |
| 18.12.12 | Holcim neutral | Banc of America Securities-Merrill Lynch | |
| 18.12.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 18.12.12 | Holcim neutral | Sarasin Research | |
| 18.12.12 | Kardex hold | Vontobel Research | |
| 18.12.12 | ALSO hold | Vontobel Research | |
| 18.12.12 | Holcim hold | Vontobel Research | |
| 17.12.12 | Holcim neutral | Citigroup Corp. | |
| 17.12.12 | Holcim buy | Citigroup Corp. | |
| 17.12.12 | Lonza hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.12.12 | Holcim hold | Vontobel Research | |
| 14.12.12 | Partners Group kaufen | Sarasin Research | |
| 14.12.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 14.12.12 | Helvetia Baloise hold | Vontobel Research | |
| 14.12.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 14.12.12 | Zurich Insurance outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 13.12.12 | Sika neutral | Sarasin Research | |
| 13.12.12 | Barry Callebaut reduce | Sarasin Research | |
| 13.12.12 | ALSO hold | Vontobel Research | |
| 13.12.12 | Sika hold | Vontobel Research | |
| 13.12.12 | Barry Callebaut hold | Vontobel Research | |
| 12.12.12 | Swatch (I) buy | Nomura | |
| 12.12.12 | Roche outperform | Credit Suisse Group | |
| 12.12.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 12.12.12 | Roche buy | Deutsche Bank AG | |
| 12.12.12 | Barry Callebaut neutral | Sarasin Research | |
| 11.12.12 | Tecan (N) buy | UBS AG | |
| 11.12.12 | Swiss Life buy | Sarasin Research | |
| 11.12.12 | Schweiter buy | UBS AG | |
| 11.12.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Roche outperform | Exane-BNP Paribas SA | |
| 11.12.12 | UBS outperform | Exane-BNP Paribas SA |